Open Writing Groups

All Close 09/19/19


How nominations to writing groups work:

  • To be considered for a writing group:

    • If you are not a PI, Co-I, or associate member, you will need a WHI PI to submit a nomination on your behalf.  Please consult the list of sponsoring PIs.

    • If you are a PI, Co-I, or associate member, you may submit a nomination on your own behalf.  After verifying you are logged into the website with your WHI username and password, please click the "Make a Nomination" link in the left-hand nomination.


  • Nominations may only be submitted by WHI PIs, Co-Investigators, and Associate Members with approved account access. PIs may nominate other investigators with appropriate research background.

  • Investigators are expected to actively participate in every writing group they sign up for and should keep their total number of nominations to a reasonable limit.


10 Open Writing Groups - All Close 09/19/2019


Ms3985 - Recreational physical activity and risk of benign proliferative epithelial disorder of the breast in the Women's Health Initiative study – Rita Peila


Ms3990 - Aircraft noise and clonal hematopoiesis of indeterminate potential – Jason M. Collins


Ms3992 - Association of clonal hematopoiesis with chronic kidney disease prevalence and progression – Nora Franceschini


Ms3993 - Effect of WHI dietary modification and weight-change on breast cancer in postmenopausal women – Delphine Lee


The following proposals are from the GECCO Consortium Study

***WHI writing group slots may be limited***


Ms4007 - Gallstones, bile acids and colorectal cancer: Mendelian randomization investigations – Neil Murphy


Ms4008 - Body mass index and colorectal cancer risk by microsatellite stability: a Mendelian randomization study – Alaina Bever


Ms4009 - ACYP2 polymorphism and aspirin use interact to influence risk of colorectal cancer – Zoe Schneider


Ms4010 - Central adiposity and colorectal cancer risk – Mark Guinter


Ms4011 - The genetic architecture of hemorrhoids disease – Andre Franke


Ms4012 - Tumour mutational signatures – Dan Buchanan